# Entasis Therapeutics, Inc.

Canonical: https://abierto.us/vendors/entasis-therapeutics-inc-p6nkp5bbsuh3

- UEI: P6NKP5BBSUH3
- CAGE: 7JD21
- Location: Waltham, MA
- Awards in window: 1 (2 transactions), -$259,639 obligated, September 23, 2025 to August 18, 2026

## Awarding agencies

- National Institutes of Health: 1 awards, -$259,639

## Industries

- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology): -$259,639

## Competition

- Full and Open Competition: 1 awards

## Largest awards

- 75N93020C00017 (definitive contract): -$259,639, National Institutes of Health Niaid. To Identify and Develop a Non-Beta-Lactam PBP Inhibitor (Nbp) with Broad Spectrum of Activity Against MDR Gram-Negative Eskape Pathogens.. https://www.usaspending.gov/award/CONT_AWD_75N93020C00017_7529_-NONE-_-NONE-/

---
Source: USAspending.gov award data, keyed by UEI. Obligations in the window only. Cite https://abierto.us/vendors/entasis-therapeutics-inc-p6nkp5bbsuh3.